DIAGNOSTIC CONSIDERATIONS AND RISK FACTOR ANALYSIS FOR MIGRAINE IN WOMEN OF FERTILE AGE

Migraine represents one of the most prevalent and debilitating neurological disorders worldwide, with a disproportionate impact on women, particularly during their reproductive years. The Global Burden of Disease Study consistently ranks migraine among the leading causes of disability globally, with women experiencing a threefold higher prevalence compared to men. This gender disparity becomes most pronounced during the fertile age period, spanning from menarche to menopause, when hormonal fluctuations significantly influence migraine patterns and severity. In the world, migraine can occur in people of any age, but the most active course of the disease in women is noted at the age of 20-45. During this period, factors such as the regularity of hormonal cycles, the use of contraceptives, pregnancy, and the postpartum period have a strong influence on the clinical course of migraine. Unlike men, in women, migraine is often associated with the menstrual cycle and exhibits specific phenotypic features of the disease.